Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Dittmann A, Nanni P, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: rodriguez de la borbolla m. Cancers (Basel). 2023 Sep 3;15(17):4407. doi: 10.3390/cancers15174407. Cancers (Basel). 2023. PMID: 37686682 Free PMC article.
Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).
Otero R, Solier-López A, Sánchez-López V, Oto J, Arellano E, Marín S, Jara-Palomares L, Elías T, Asencio MI, Blasco-Esquivias I, Rodríguez de la Borbolla M, Sánchez-Díaz JM, Real-Domínguez M, García-Cabrera E, Rodríguez-Martorell FJ, Medina P. Otero R, et al. Among authors: rodriguez de la borbolla m. Cancers (Basel). 2022 Jun 2;14(11):2771. doi: 10.3390/cancers14112771. Cancers (Basel). 2022. PMID: 35681751 Free PMC article.
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Zapater-Moros A, López-Camacho E, Lumbreras-Herrera MI, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos R, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: rodriguez de la borbolla m. Int J Mol Sci. 2023 Jan 2;24(1):801. doi: 10.3390/ijms24010801. Int J Mol Sci. 2023. PMID: 36614248 Free PMC article.
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.
Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, Asensio-Cruz MI, Blasco-Esquivias I, Sanchez-Lopez V, de la Borbolla MR, Arellano-Orden E, Suarez-Valdivia L, Marin-Romero S, Marin-Barrera L, Ruiz-Garcia A, Montero-Romero E, Navarro-Herrero S, Lopez-Campos JL, Serrano-Gotarredona MP, Praena-Fernandez JM, Sanchez-Diaz JM, Otero-Candelera R. Jara-Palomares L, et al. Among authors: de la borbolla mr. Br J Cancer. 2018 Oct;119(8):915-921. doi: 10.1038/s41416-018-0269-5. Epub 2018 Oct 15. Br J Cancer. 2018. PMID: 30318508 Free PMC article.